使用组合策略改善CD3双特异抗体治疗固体瘤
Katy Lloyd1, Jim Middelburg2, Vitalijs Ovcinnikovs1
1Genmab B.V., Utrecht, Netherlands.
Frontiers in oncology
|February 25, 2025
概括
CD3双特异性抗体对固体瘤有希望,但面临着挑战. 正在探索组合策略,以克服瘤微环境并改善T细胞反应,以更好地治疗癌症.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 癌症研究 癌症研究
背景情况:
- CD3双特异性抗体 (bsAbs) 越来越多地被用于瘤学.
- 美国食品和药物管理局批准的CD3 bsAbs存在于血液和固体瘤.
- 固体瘤治疗仍然存在挑战,包括T细胞透和免疫抑制瘤微环境.
研究的目的:
- 审查目前关于固体癌症中CD3 bsAbs组合方法的研究.
- 在固体瘤中确定克服CD3 bsAbs限制的策略.
- 讨论针对治疗疗效和安全的抗原选择.
主要方法:
- 关于CD3 bsAbs和组合疗法的最新研究的文献综述.
- 对限制CD3bsAbs在固体瘤中的有效性因素的分析.
- 探索增强T细胞活动和克服瘤抵抗力的策略.
主要成果:
- 内T细胞数量有限阻碍了CD3 bsAb的有效性.
- 免疫抑制性瘤微环境阻碍了抗瘤反应.
- 记忆力差的T细胞诱导会影响长期疗效.
- 优化瘤抗原选择对于平衡疗效和毒性至关重要.
结论:
- 组合疗法对于提高CD3 bsAb在固体瘤中的疗效至关重要.
- 解决TME和改善T细胞记忆是关键的研究领域.
- 谨慎的抗原选择对于成功的临床转换至关重要.
关键词:
CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD3 CD4 CD4 CD4 CD4 CD4 CD5 CD5 CD5 CD5 CD6 CD7 CD7 CD7 CD7 CD7 CD7 CD8 CD7 CD8 CD8 CD8 CD8 CD8 CD8 CD9抗体是一种抗体.两种特定的Ab Ab.癌症 癌症 癌症 癌症 癌症接种疫苗 接种疫苗更多相关视频
07:36Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody
Published on: May 16, 2020
5.2K
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
12.1K
相关概念视频
01:27Tumor Immunotherapy
463
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
463
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K